William J O'Brien1, Kalpana Gupta2, Kamal M F Itani3. 1. VA Boston Center for Healthcare Organization and Implementation Research, Boston, MA USA. 2. VA Boston Dept. of Medicine, Boston, MA USA. 3. VA Boston Dept. of Surgery, Boston, MA USA.
Abstract
BACKGROUND: Postoperative infections are a common and often preventable complication of surgery. S. aureus is a prevalent organism cultured in these infections and is associated with morbidity, mortality, and increased healthcare utilization. However, the long-term burden of S. aureus infection in surgical patients is not well studied. The purpose of this retrospective observational study is to assess the incidence, time trend, and burden of S. aureus infection up to 1 year after surgery. METHODS: We obtained manually-reviewed data from the VA Surgical Quality Improvement Program (VASQIP) to identify surgeries in all major specialties. These were combined with laboratory microbiology and pharmacy data to identify pneumonia and infections of the urinary tract, surgical site, and blood. RESULTS: In the study population of 559,550 patients, S. aureus incidence decreased each year, from 2.1% in 2008 to 1.1% in 2015. Among these, incidence of methicillin-resistant S. aureus (MRSA) infection decreased from 0.7% to 0.4%, and methicillin-susceptible S. aureus (MSSA) decreased from 1.4% to 0.7%. S. aureus infection was associated with increased length of stay, ED utilization, inpatient admissions, as well as a 4-fold increase in mortality. CONCLUSIONS: This is one of the largest studies describing the long-term incidence of S. aureus in the surgical population of a national integrated healthcare system. We conclude that the burden of S. aureus infection extends well beyond the conventional 30-day postoperative window, and late infection should be included in assessing the effects of interventions. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2019. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND:Postoperative infections are a common and often preventable complication of surgery. S. aureus is a prevalent organism cultured in these infections and is associated with morbidity, mortality, and increased healthcare utilization. However, the long-term burden of S. aureus infection in surgical patients is not well studied. The purpose of this retrospective observational study is to assess the incidence, time trend, and burden of S. aureus infection up to 1 year after surgery. METHODS: We obtained manually-reviewed data from the VA Surgical Quality Improvement Program (VASQIP) to identify surgeries in all major specialties. These were combined with laboratory microbiology and pharmacy data to identify pneumonia and infections of the urinary tract, surgical site, and blood. RESULTS: In the study population of 559,550 patients, S. aureus incidence decreased each year, from 2.1% in 2008 to 1.1% in 2015. Among these, incidence of methicillin-resistant S. aureus (MRSA) infection decreased from 0.7% to 0.4%, and methicillin-susceptible S. aureus (MSSA) decreased from 1.4% to 0.7%. S. aureus infection was associated with increased length of stay, ED utilization, inpatient admissions, as well as a 4-fold increase in mortality. CONCLUSIONS: This is one of the largest studies describing the long-term incidence of S. aureus in the surgical population of a national integrated healthcare system. We conclude that the burden of S. aureus infection extends well beyond the conventional 30-day postoperative window, and late infection should be included in assessing the effects of interventions. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2019. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: David H Kim; Maureen Spencer; Susan M Davidson; Ling Li; Jeremy D Shaw; Diane Gulczynski; David J Hunter; Juli F Martha; Gerald B Miley; Stephen J Parazin; Pamela Dejoie; John C Richmond Journal: J Bone Joint Surg Am Date: 2010-07-07 Impact factor: 5.284
Authors: S F Khuri; J Daley; W Henderson; K Hur; J Demakis; J B Aust; V Chong; P J Fabri; J O Gibbs; F Grover; K Hammermeister; G Irvin; G McDonald; E Passaro; L Phillips; F Scamman; J Spencer; J F Stremple Journal: Ann Surg Date: 1998-10 Impact factor: 12.969
Authors: Craig A Umscheid; Matthew D Mitchell; Jalpa A Doshi; Rajender Agarwal; Kendal Williams; Patrick J Brennan Journal: Infect Control Hosp Epidemiol Date: 2011-02 Impact factor: 3.254
Authors: Richard E Nelson; Vanessa W Stevens; Makoto Jones; Matthew H Samore; Michael A Rubin Journal: Am J Infect Control Date: 2015-01 Impact factor: 2.918
Authors: C E Marculescu; E F Berbari; A D Hanssen; J M Steckelberg; S W Harmsen; J N Mandrekar; D R Osmon Journal: Clin Infect Dis Date: 2006-01-05 Impact factor: 9.079
Authors: Samir S Awad; Carlos H Palacio; Anuradha Subramanian; Patricia A Byers; Paula Abraham; Debra A Lewis; Edward J Young Journal: Am J Surg Date: 2009-11 Impact factor: 2.565